Ansun Biopharma

Ansun Biopharma

Biotechnology, Sorrento Valley Rd Ste 12, San Diego, , 92121, California, 11568, United States, 11-50 Employees

ansunbiopharma.com

  • facebook
  • twitter
  • LinkedIn

Who is ANSUN BIOPHARMA

Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics. Our lead pro...

Read More

map
  • 11568 Sorrento Valley Rd Ste 12, San Diego, California, 92121, United States Headquarters: 11568 Sorrento Valley Rd Ste 12, San Diego, California, 92121, United States
  • 2003 Date Founded: 2003
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 325412 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from ANSUN BIOPHARMA

Ansun Biopharma Org Chart and Mapping

Employees

Carrie Hansen

Executive Director, Clinical Affairs

Keshav Karki

Senior Scientist at Ansun Biopharma Inc.

Lana Ordonez

Senior Regulatory Associate

Stephen Hawley

Senior Principal Scientist

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Ansun Biopharma

Answer: Ansun Biopharma's headquarters are located at Sorrento Valley Rd Ste 12, San Diego, , 92121, California, 11568, United States

Answer: Ansun Biopharma's official website is https://ansunbiopharma.com

Answer: Ansun Biopharma's revenue is $1 Million to $5 Million

Answer: Ansun Biopharma's SIC: 2834

Answer: Ansun Biopharma's NAICS: 325412

Answer: Ansun Biopharma has 11-50 employees

Answer: Ansun Biopharma is in Biotechnology

Answer: Ansun Biopharma contact info: Phone number: Website: https://ansunbiopharma.com

Answer: Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics. Our lead product, DAS181, is a multi-function sialidase fusion protein for host-cellprotection in respiratory virus infection, including parainfluenza, influenza and COVID19,. We are also advancing several additional programs in oncology and autoimmune diseases using our sialidase platform technology.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access